trial · primary record
Zanubrutinib
Mantle Cell Lymphoma
| Phase | Phase 3 |
|---|---|
| Status | RECRUITING |
| Sponsor | Unknown |
| Enrolment | 421 |
| Primary completion | 2038-08-31 |
| Primary endpoint | Progression-free survival (PFS) 1 (Arm A) |
| Registry ID | NCT05976763 |
Provenance
- Source: ClinicalTrials.gov
- Fetched at: 2026-11-04T03:54:39.749Z
- Licence class: attribution-required
- Verdict: primary-source
- Entity id: NCT05976763
This record is rendered from the AEaH spine. If the source is unreachable the page is not generated.
Same entity, elsewhere in the suite
- Zanubrutinib · approval
- Zanubrutinib · compound